Explore our sister journals here.

Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIRx Med

Date Submitted: Aug 27, 2021
Date Accepted: Aug 27, 2021

The final, peer-reviewed published version of this preprint can be found here:

Authors’ Response to Peer Reviews of “Selection of the Optimal L-asparaginase II Against Acute Lymphoblastic Leukemia: An In Silico Approach”

Baral A, Gorkhali R, Basnet A, Koirala S, Bhattarai HK

Authors’ Response to Peer Reviews of “Selection of the Optimal L-asparaginase II Against Acute Lymphoblastic Leukemia: An In Silico Approach”

JMIRx Med 2021;2(3):e33217

DOI: 10.2196/33217

PMCID: 10414483

Authors’ Responses to Peer Review Reports

  • Adesh Baral; 
  • Ritesh Gorkhali; 
  • Amit Basnet; 
  • Shubham Koirala; 
  • Hitesh Kumar Bhattarai

ABSTRACT

“These are the authors’ responses to peer review reports related to MS ID[29844].”


 Citation

Please cite as:

Baral A, Gorkhali R, Basnet A, Koirala S, Bhattarai HK

Authors’ Response to Peer Reviews of “Selection of the Optimal L-asparaginase II Against Acute Lymphoblastic Leukemia: An In Silico Approach”

JMIRx Med 2021;2(3):e33217

DOI: 10.2196/33217

PMCID: 10414483

Per the author's request the PDF is not available.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.